Zhao Jiayang, vice president and senior analyst of Bbüü Capital, believes that under the pressure of the outflow of funds from Hong Kong stocks, it is difficult for technology stocks to reverse the low valuation in the short term. Biomedicine valuation is high, focus on leading enterprises. Green electricity into...
Biomedicine Valuation Asia pacific Leading enterprises Outstanding capital Vice President
12-17